Skip to content

Director – Hta – Value & Evidence – Specialty Care – GI
Company | Pfizer |
---|
Location | New York, NY, USA |
---|
Salary | $169700 – $282900 |
---|
Type | Full-Time |
---|
Degrees | Master’s, PhD |
---|
Experience Level | Senior, Expert or higher |
---|
Requirements
- Graduate degree (e.g. MSc, MPH, PhD) required; 7+ years of experience with MSc/MPH/MBA degree; 5+ years with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
- Demonstrated expert understanding of fundamental health services research methods and tools including but not limited to: Health economics, Cost-effectiveness / budgetary impact modeling, Patient reported outcomes measures, Real world evidence studies, Epidemiology, Statistics
- Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
- Strong interpersonal skills and evidence of teamwork in a matrix environment
- Demonstrated ability to manage multiple projects with autonomy, involving complex processes, significant budget, competing deadlines, and rapidly shifting priorities in a compliant manner
- Proven ability to develop strong partnerships across multiple functions within a large group/company
- A track record with an “execution mindset” focused on getting things done quickly and simply
- Ability to understand, synthesize, and summarize complex topics
- Excellent oral and written English communication skills
Responsibilities
- Lead the development of the HTA, Value & Evidence Strategy to support the access values of assets in close partnership with the cross-functional matrix team
- Work closely with PRD, CMAO, WRD, and commercial to ensure that their access evidence/HEOR needs are met
- Work with cross-functional teams to ensure an aligned value and evidence plan at the Global level
- Develop real world evidence generation strategies and lead the design and execution of studies (e.g., treatment patterns, real world effectiveness, burden of illness studies, epidemiology studies, etc.) to generate evidence to support brand competitive differentiation and value proposition
- Lead the execution of clinically relevant and scientifically valid, cutting edge HEOR studies and projects (including non-interventional studies, registries, etc.) in alignment with the global HEOR strategy catered to diverse stakeholders (regulators, payers, patients, physicians and policy makers)
- Lead the development of appropriate data dissemination plans and communicate in a timely manner
- Remain fully compliant to all Pfizer SOPs (Standard Operating Procedures)
Preferred Qualifications
- Experience working with private and public payers, from US markets to HTA organizations such as NICE, CADTH, ICER and other reimbursement bodies is strongly preferred
- Executive presence and ability to independently engage all levels of stakeholders within all levels of the organization
- Knowledge and experience in I&I therapeutic areas is desirable
- Launch experience is preferred